Heparin Product Offering Now Among Broadest Available LAKE FOREST, Ill., Aug. 31 (HSMN NewsFeed) — Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) ha…
Biopharmaceuticals, FDA
Hospira, heparin, anticoagulant
Posts on ‘August 31st, 2009’
Hospira Receives FDA Approval for Six New Presentations of Heparin
Merck CEO Announces Structure and Global Leadership Team for New Merck
New Structure to Capitalize on Growth Opportunities in Emerging Markets, Biologics, Vaccines, Animal Health and Consumer Health Care Merger Planning on Track; Expected to Close in Fourth Quarter New Merck Organized to Maximize Broader Product Portf…
Biopharmaceuticals, Personnel
Merck
Prospera Technologies Announces Groundbreaking Scientific Controlled Research Showing Excellent Outcomes for Negative Pressure Wound Therapy Using Gauze
FORT WORTH, Texas–(HSMN NewsFeed)–At the 5th Joint Meeting of the European Tissue Repair Society and The Wound Healing Society in Limoges, France, Associate Professor Malin Malmsjo, MD, PhD of Lund University in Sweden presented never before seen ground-…
Devices, Wound Care
Prospera, Negative Pressure Wound Therapy
Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
PLAINSBORO, N.J., Aug. 31, 2009 –(HSMN NewsFeed) — Integra LifeSciences Holdings Corporation (Nasdaq:IART ) is featuring the MAYFIELD® Infinity XR2 Radiolucent Cranial Stabilization System at the XIV World Congress of Neurological Surgery in Boston, …
Devices, Neurosurgery
Integra LifeSciences, MAYFIELD Infinity XR2, Radiolucent Cranial Stabilization

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.